Hui-Hua Chang, Ph.D.
Affiliations: | 2013 | Nutritional Sciences | University of Arizona, Tucson, AZ |
Area:
Pharmacology, Oncology, BiochemistryGoogle:
"Hui-Hua Chang"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Emmanuelle J. Meuillet | grad student | 2013 | University of Arizona | |
| (Discovery and characterization of novel inhibitors of the prostaglandin E2 pathway.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dong TS, Chang HH, Hauer M, et al. (2019) Metformin Alters the Duodenal Microbiome and Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity. American Journal of Physiology. Gastrointestinal and Liver Physiology |
| Chang HH, Eibl G. (2019) Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma. Cells. 8 |
| Hao F, Xu Q, Wang J, et al. (2019) Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice. Plos One. 14: e0216603 |
| Hao F, Xu Q, Wang J, et al. (2019) Sa2010 – Lipophilic Statins Inhibit Yap Nuclear Localization, Coactivator Activity and Colony Formation in Pancreatic Cancer Cells and Prevent the Initial Stages of Pancreatic Ductal Adenocarcinoma in Kras Mice Gastroenterology. 156 |
| Xu M, Chang HH, Jung X, et al. (2018) Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice. Bmc Cancer. 18: 797 |
| Kaur K, Chang HH, Topchyan P, et al. (2018) Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice. Frontiers in Immunology. 9: 1229 |
| Chang HH, Moro A, Chou CEN, et al. (2018) Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model. Scientific Reports. 8: 5899 |
| Takakura K, Speakman S, Chang H, et al. (2018) Tu1343 - TP53 Determines the Effects of Beclin1 Haploinsufficiency on Autophagy and Tumorigenesis in a Kras G12D Mouse Model of Pancreatic Cancer Gastroenterology. 154: S-937 |
| Chang H, Sinnett-Smith J, Schmidt AI, et al. (2018) Mo1988 - Metformin Prevents Kras-Mutant Pancreatic Ductal Adenocarcinoma Promoted by Diet-Induced Obesity Gastroenterology. 154: S-873 |
| Chang H, Sinnett-Smith J, Hines OJ, et al. (2018) Metformin prevents obesity-promoted pancreatic cancer development in the conditional KrasG12D mouse model Pancreatology. 18: S153 |